AU Stock MarketDetailed Quotes
ZLD Zelira Therapeutics Ltd
- 0.670
- -0.030-4.29%
20min DelayMarket Closed Sep 13 15:45 AET
7.60MMarket Cap-207P/E (Static)
0.700High0.670Low2.25KVolume0.700Open0.700Pre Close1.55KTurnover1.10252wk High0.04%Turnover Ratio11.35MShares0.28052wk Low-3.223EPS TTM4.13MFloat Cap5625176.649Historical HighLossP/E (Static)6.16MShs Float0.280Historical Low-3.223EPS LYR4.29%Amplitude--Dividend TTM-1.68P/B1Lot Size--Div YieldTTM
Zelira Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -68.47%94.95K | -80.45%301.12K | 256.16%1.54M | 432.57K | ||||||
| Operating revenue | -68.47%94.95K | -80.45%301.12K | 256.16%1.54M | --432.57K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cost of revenue | -76.65%84.67K | -61.39%362.56K | 311.47%939.05K | 228.22K | ||||||
| Gross profit | 116.74%10.28K | -110.21%-61.44K | 194.39%601.57K | 204.35K | ||||||
| Operating expense | -17.40%5.95M | -49.45%7.2M | 39.74%14.25M | 28.46%10.2M | 87.26%7.94M | 49.86%4.24M | -55.28%2.83M | 621.62%6.32M | 106.79%876.42K | 43.58%423.83K |
| Selling and administrative expenses | -56.33%1.34M | -49.62%3.06M | 35.36%6.08M | 127.51%4.49M | 57.57%1.97M | 215.23%1.25M | -70.52%397.37K | 194.96%1.35M | 119.95%456.94K | 15.42%207.75K |
| -General and administrative expense | -56.33%1.34M | -49.62%3.06M | 35.36%6.08M | 127.51%4.49M | 57.57%1.97M | 215.23%1.25M | -70.52%397.37K | 194.96%1.35M | 119.95%456.94K | 15.42%207.75K |
| Research and development costs | ---- | --1.34M | ---- | --2.08M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation amortization depletion | -12.14%479.04K | -7.36%545.22K | 24.10%588.54K | 72.42%474.26K | --275.05K | ---- | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | -12.14%479.04K | -7.36%545.22K | 24.10%588.54K | 72.42%474.26K | --275.05K | ---- | ---- | ---- | ---- | ---- |
| Provision for doubtful accounts | ---- | -196.71%-1.46M | --1.51M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | 11.13%4.13M | -38.75%3.72M | 92.72%6.07M | -44.63%3.15M | 90.50%5.69M | 22.83%2.99M | -51.16%2.43M | 1,086.39%4.98M | 94.13%419.48K | 88.16%216.08K |
| Operating profit | 18.24%-5.94M | 46.77%-7.26M | -36.58%-13.65M | -25.88%-9.99M | -87.26%-7.94M | -49.86%-4.24M | 55.28%-2.83M | -621.62%-6.32M | -106.79%-876.42K | -43.58%-423.83K |
| Net non-operating interest income (expenses) | -865.62%-738.96K | -76.93%-76.53K | -3.22%-43.25K | -1,019.53%-41.9K | -104.15%-3.74K | -34.95%90.14K | 104.64%138.57K | 2,380.40%67.72K | -76.44%2.73K | -44.13%11.59K |
| Non-operating interest income | 130.60%309 | -98.74%134 | 1,365.42%10.6K | -91.59%723 | -90.46%8.6K | -34.95%90.14K | 104.64%138.57K | 2,380.40%67.72K | -76.44%2.73K | -44.13%11.59K |
| Non-operating interest expense | 864.34%739.27K | 42.37%76.66K | 26.32%53.85K | 245.33%42.63K | --12.34K | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -2,907.16%-30.06M | -16.02%1.07M | -14.07%1.28M | 60.35%1.48M | 59.45%925.49K | -39.53%580.44K | 866.21%959.82K | 498.22%99.34K | -305.13%-24.95K | 177.08%12.16K |
| Special income (charges) | -11,528.35%-30.99M | ---266.52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | 11,528.35%30.99M | --266.52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -30.56%928.74K | 4.88%1.34M | -14.07%1.28M | 60.35%1.48M | 59.45%925.49K | -39.53%580.44K | 866.21%959.82K | 498.22%99.34K | -305.13%-24.95K | 177.08%12.16K |
| Income before tax | -486.08%-36.74M | 49.50%-6.27M | -45.20%-12.41M | -21.87%-8.55M | -96.62%-7.02M | -106.25%-3.57M | 71.91%-1.73M | -585.19%-6.16M | -124.61%-898.64K | -37.86%-400.08K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -486.08%-36.74M | 49.50%-6.27M | -45.20%-12.41M | -21.87%-8.55M | -96.62%-7.02M | -106.25%-3.57M | 71.91%-1.73M | -585.19%-6.16M | -124.61%-898.64K | -37.86%-400.08K |
| Net income continuous operations | -486.08%-36.74M | 49.50%-6.27M | -45.20%-12.41M | -21.87%-8.55M | -96.62%-7.02M | -106.25%-3.57M | 71.91%-1.73M | -585.19%-6.16M | -124.61%-898.64K | -37.86%-400.08K |
| Noncontrolling interests | 75.44%-170.86K | -48.59%-695.73K | -468.22K | |||||||
| Net income attributable to the company | -556.18%-36.57M | 53.35%-5.57M | -39.73%-11.95M | -21.87%-8.55M | -96.62%-7.02M | -106.25%-3.57M | 71.91%-1.73M | -585.19%-6.16M | -124.61%-898.64K | -37.86%-400.08K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -556.18%-36.57M | 53.35%-5.57M | -39.73%-11.95M | -21.87%-8.55M | -96.62%-7.02M | -106.25%-3.57M | 71.91%-1.73M | -585.19%-6.16M | -124.61%-898.64K | -37.86%-400.08K |
| Diluted earnings per share | -482.24%-3.2227 | 64.14%-0.5535 | -20.82%-1.5435 | 12.05%-1.2776 | -76.60%-1.4526 | -104.35%-0.8225 | 81.45%-0.4025 | -55.00%-2.1701 | -100.00%-1.4001 | -33.33%-0.7 |
| Basic earnings per share | -482.24%-3.2227 | 64.14%-0.5535 | -20.82%-1.5435 | 12.05%-1.2776 | -76.60%-1.4526 | -104.35%-0.8225 | 81.45%-0.4025 | -55.00%-2.1701 | -100.00%-1.4001 | -33.33%-0.7 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data